Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has shared an update.
Suzhou Basecare Medical Corporation Limited has announced the convening of its 2025 first class meeting for holders of H shares, scheduled for June 5, 2025. The meeting will address a special resolution to amend the Articles of Association, which could impact the company’s governance and operational structure. The results of the meeting will be published on the company’s and Hong Kong Exchanges’ websites, providing transparency to stakeholders.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corporation Limited is a company based in the People’s Republic of China, operating in the medical industry. It focuses on providing medical products and services, with a specific market focus on genetic testing and related healthcare solutions.
YTD Price Performance: 8.76%
Average Trading Volume: 167,530
Technical Sentiment Signal: Sell
Current Market Cap: HK$842.5M
For a thorough assessment of 2170 stock, go to TipRanks’ Stock Analysis page.